Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
information, which it said could result in "critical misstatements and omissions." USPTO director Kathi Vidal said in a statement that the guidance was "part of our work shaping AI policy" and "encourages
April 16, 2025 , the U.S. Patent and Trademark Office (USPTO) announced creating a new group to expand the agency's efforts to mitigate threats and protect the integrity of the U.S. patent system.
from a Massachusetts court underscores this tightrope walk, and serves as a warning that claims drafted too loosely—while allowed by the USPTO—can leave the patent at risk for invalidation by
The US Patent and Trademark Office (USPTO) has outlined targets to reduce the time it takes to process patent applications, Andrei Iancu, director of the USPTO, has said. Addressing a Senate panel
property landscape. On April 15, 2014, the US Patent and Trademark Office (USPTO) awarded the first patent for use the CRISPR/Cas system to edit eukaryotic genomes to Feng Zhang of the Broad Institute
each particular system supporting those applications”. US Patent and Trademark Office (USPTO) director Andrei Iancu acted on behalf of several private companies in filing two inter partes reviews that
Act (AIA) in 2011, patent practitioners thought that the USPTO was issuing too many “bad” patents. In response, Congress created IPRs which were intended to be a less expensive and quicker (compared
examination instructions for analyzing the subject matter eligibility of patent claims under 35 U.S.C. § 101—supplements the USPTO’s two, previously-issued examination instructions: the 2014 Interim
, or a registration obtained, before the new rule is implemented, the USPTO will not require a U.S. attorney be appointed. But, if the USPTO issues an Office Action or if a statement of use becomes due
March 5 - Pfizer (PFE.N) and BioNTech (22UAy.DE) won a round in their legal battle with Moderna (MRNA.O) over COVID-19 vaccine patents on Wednesday, convincing a U.S. Patent Office tribunal that two p...
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
